Dynacin Related Published Studies
Well-designed clinical trials related to Dynacin (Minocycline)
Glatiramer Acetate in Combination with Minocycline in Patients with Relapsing-Remitting Multiple Sclerosis: Results of a Canadian, Multicenter, Double-Blind, Placebo-Controlled Trial. [2009.09.23]
Local minocycline as an adjunct to surgical therapy in moderate to severe, chronic periodontitis. [2008.06]
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. [2007.12.01]
Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. [2007.05.01]
Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone. [2006.12]
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. [2006.10]
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. [2006.05]
Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: a randomized clinical trial. [2006.05]
Additional minocycline pleurodesis after thoracoscopic surgery for primary spontaneous pneumothorax. [2006.03.01]
A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. [2006.03]
Longitudinal clinical evaluation of adjunct minocycline in the treatment of chronic periodontitis. [2006.02]
Supportive periodontal therapy using mechanical instrumentation or 2% minocycline gel: a 12 month randomized, controlled, single masked pilot study. [2006.02]
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. [2006.01]
Minocycline in amyotrophic lateral sclerosis: a pilot study. [2005.10]
A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. [2005.06]
Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis. [2005.02]
Well-designed clinical trials possibly related to Dynacin (Minocycline)
Effect of antimicrobial periodontal treatment and maintenance on serum adiponectin in type 2 diabetes mellitus. [2009.02]
Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin. [2009.01]
Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience. [2008.10]
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective. [2008.10]
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections - the European experience. [2008.10]
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. [2008.09]
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. [2008.07]
Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial. [2008.02]
Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections. [2008.01]
Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. [2008]
Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. [2007.12]
Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. [2007.10.17]
Infection reduction using antibiotic-coated inflatable penile prosthesis. [2007.08]
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections. [2007.06]
Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin. [2007.04]
A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. [2006.03]
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. [2005.11]
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. [2005.10.19]
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. [2005.09.01]
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. [2005.09]
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. [2005.08]
Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. [2005.03]
Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens. [2005.01]
Combined effects of Nd:YAG laser irradiation with local antibiotic application into periodontal pockets. [2005.01]
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. [2005.01]
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. [2005.01]
Other research related to Dynacin (Minocycline)
Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. [2009.09.16]
Central administration of minocycline and riluzole prevents morphine-induced tolerance in rats. [2009.09]
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. [2009.09]
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. [2009.07.01]
Minocycline-induced pigmentation mimicking persistent ecchymosis. [2009.07]
[A case of hypertrophic pachymeningitis treated successfully with antibiotics: the remarkable effect of minocycline hydrochloride in reducing the serum C-reactive protein value] [2009.07]
Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy. [2009.07]
Correlates of quality of life in ALS: Lessons from the minocycline study. [2009.06.23]
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. [2009.05.29]
The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. [2009.05.01]
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding. [2009.04]
Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans. [2009.03]
Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. [2009.01]
Protective effect of minocycline on dexamethasone induced testicular germ cell apoptosis in mice. [2009.01]
Brain and plasma riluzole pharmacokinetics: effect of minocycline combination. [2009]
A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. [2008.12.03]
Extension of the thrombolytic time window with minocycline in experimental stroke. [2008.12]
[Achievement of sputum culture negative conversion by minocycline in a case with extensively drug-resistant pulmonary tuberculosis] [2008.11]
MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline. [2008.11]
A novel non-antibacterial, non-chelating hydroxypyrazoline derivative of minocycline inhibits nociception and oedema in mice. [2008.11]
Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats. [2008.10.01]
Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. [2008.10]
[Minocycline for the treatment of amyotrophic lateral sclerosis: neuroprotector or neurotoxin? Reflections on another failure of translational medicine.] [2008.10]
[Case of minocycline-induced acute eosinophilic pneumonia accompanied by marked neutrophilia in the peripheral blood] [2008.10]
Clinical potential of minocycline for schizophrenia. [2008.10]
A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. [2008.09.24]
Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection. [2008.09.23]
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. [2008.09.10]
A double-blind randomized clinical trial of subgingival minocycline for chronic periodontitis. [2008.09]
Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir. [2008.09]
Chronic minocycline-induced autoimmunity in children. [2008.09]
Minocycline hepatitis. [2008.08]
Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. [2008.08]
The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice. [2008.08]
[Is good old minocycline a new neuroprotective drug?] [2008.07.01]
Drug-induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland. [2008.07]
Minocycline protects motor but not autonomic neurons after cauda equina injury. [2008.07]
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. [2008.06]
Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. [2008.06]
Severe lactic acidosis secondary to minocycline in a teenager with infectious mononucleosis and mitochondrial myopathy. [2008.06]
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. [2008.05.13]
Minocycline treatment results in reduced oral steroid requirements in adult asthma. [2008.05]
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. [2008.05]
Pilot study of minocycline in relapsing-remitting multiple sclerosis. [2008.05]
Combined treatment with atorvastatin and minocycline suppresses severity of EAE. [2008.05]
Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion. [2008.04]
Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. [2008.04]
Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. [2008.03]
Minocycline-induced hyperpigmentation in rheumatoid arthritis. [2008.02]
[Minocycline as a therapeutic drug for methamphetamine use disorders] [2008.02]
[Case of acute eosinophilic pneumonia probably induced by minocycline] [2008.02]
Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat-Effects on BBB breakdown and MMP expression in the acute and subacute phase. [2008.01.10]
Topical minocycline for managing symptoms of recurrent aphthous stomatitis. [2008.01]
Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. [2008.01]
A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. [2008.01]
[Confluent and reticulated Gougerot-Carteaud papillomatosis: a case report of an excellent response to minocycline] [2008.01]
Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. [2008]
Minocycline-induced DRESS: evidence for accumulation of the culprit drug. [2008]
Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. [2007.12.08]
|
